Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Classifica tra le azioni #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Prezzo delle azioni
$3.86
Capitalizzazione di mercato
$21.49M
Variazione (1 giorno)
-0.17%
Variazione (1 anno)
-25.27%
Paese
JP
Scambia Human Metabolome Technologies, Inc. (6090)

Categoria

Storico del prezzo dell'azione per Human Metabolome Technologies, Inc. (6090)
Prezzo di chiusura più alto: $3.90 il 2026-08-01

Prezzo di chiusura più basso: $38.92 il 2013-12-01
Storico del prezzo dell'azione di Human Metabolome Technologies, Inc. dal 2013 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 6.42%
2025 5.53%
2024 -8.60%
2023 -16.34%
2022 -3.84%
2021 -27.40%
2020 -0.20%
2019 -31.00%
2018 -39.33%
2017 33.64%
2016 94.29%
2015 -35.63%
2014 -72.82%
2013 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$543.58 39.11%
US
$1.02K 55.96%
NL
$149.47 435.54%
US
$117.42 -19.34%
AU
$755.62 8.92%
CH